178 related articles for article (PubMed ID: 20335266)
1. Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry.
Delos SE; La B; Gilmartin A; White JM
J Virol; 2010 Jun; 84(11):5687-94. PubMed ID: 20335266
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of a fusion glycoprotein from a retrovirus that undergoes a hybrid 2-step entry mechanism.
Aydin H; Smrke BM; Lee JE
FASEB J; 2013 Dec; 27(12):5059-71. PubMed ID: 24036886
[TBL] [Abstract][Full Text] [Related]
3. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.
Matsuyama S; Delos SE; White JM
J Virol; 2004 Aug; 78(15):8201-9. PubMed ID: 15254191
[TBL] [Abstract][Full Text] [Related]
4. Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein.
Delos SE; White JM
J Virol; 2000 Oct; 74(20):9738-41. PubMed ID: 11000247
[TBL] [Abstract][Full Text] [Related]
5. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
Delos SE; Godby JA; White JM
J Virol; 2005 Mar; 79(6):3488-99. PubMed ID: 15731243
[TBL] [Abstract][Full Text] [Related]
6. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.
Earp LJ; Delos SE; Netter RC; Bates P; White JM
J Virol; 2003 Mar; 77(5):3058-66. PubMed ID: 12584331
[TBL] [Abstract][Full Text] [Related]
7. Alpharetrovirus envelope-receptor interactions.
Barnard RJ; Young JA
Curr Top Microbiol Immunol; 2003; 281():107-36. PubMed ID: 12932076
[TBL] [Abstract][Full Text] [Related]
8. Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits.
Damico R; Rong L; Bates P
J Virol; 1999 Apr; 73(4):3087-94. PubMed ID: 10074159
[TBL] [Abstract][Full Text] [Related]
9. The central proline of an internal viral fusion peptide serves two important roles.
Delos SE; Gilbert JM; White JM
J Virol; 2000 Feb; 74(4):1686-93. PubMed ID: 10644338
[TBL] [Abstract][Full Text] [Related]
10. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.
Melikyan GB; Barnard RJ; Markosyan RM; Young JA; Cohen FS
J Virol; 2004 Apr; 78(7):3753-62. PubMed ID: 15016895
[TBL] [Abstract][Full Text] [Related]
11. A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.
Melder DC; Yin X; Delos SE; Federspiel MJ
J Virol; 2009 Sep; 83(17):8575-86. PubMed ID: 19515762
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain.
Balliet JW; Gendron K; Bates P
J Virol; 2000 Apr; 74(8):3731-9. PubMed ID: 10729148
[TBL] [Abstract][Full Text] [Related]
13. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
[TBL] [Abstract][Full Text] [Related]
14. Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection.
Rong L; Edinger A; Bates P
J Virol; 1997 May; 71(5):3458-65. PubMed ID: 9094617
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
Maerz AL; Drummer HE; Wilson KA; Poumbourios P
J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
[TBL] [Abstract][Full Text] [Related]
16. Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating.
Barnard RJ; Narayan S; Dornadula G; Miller MD; Young JA
J Virol; 2004 Oct; 78(19):10433-41. PubMed ID: 15367609
[TBL] [Abstract][Full Text] [Related]
17. Visualization of the two-step fusion process of the retrovirus avian sarcoma/leukosis virus by cryo-electron tomography.
Cardone G; Brecher M; Fontana J; Winkler DC; Butan C; White JM; Steven AC
J Virol; 2012 Nov; 86(22):12129-37. PubMed ID: 22933285
[TBL] [Abstract][Full Text] [Related]
18. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
[TBL] [Abstract][Full Text] [Related]
19. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
[TBL] [Abstract][Full Text] [Related]
20. Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion.
Côté M; Zheng YM; Liu SL
J Virol; 2009 Nov; 83(22):11447-55. PubMed ID: 19726505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
